Barbara Schmidt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Barbara Schmidt has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
Robin S. Roberts
Department of Clinical Epidemiology and Biostatistics McMaster University Hamilton, Ontario, Canada
10 shared publicationsRobin Roberts
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
6 shared publicationsAlfonso Solimano
Department of Pediatrics, University of British Columbia, Vancouver, Canada
5 shared publicationsDiane Moddemann
5 shared publicationsElizabeth V. Asztalos
Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada
5 shared publicationsArne Ohlsson
4 shared publications
Latest Publications
- 1 July 2017
- Published by Elsevier in The Journal of Pediatrics
- Vol. 186, 9-10
Oxygen Targeting in Infants Born Extremely Preterm Who Are Small for Gestational Age: A Need for Heightened Vigilance
- 1 July 2017
- Published by Elsevier in The Journal of Pediatrics
- Vol. 186, 9-10
Oxygen Targeting in Infants Born Extremely Preterm Who Are Small for Gestational Age: A Need for Heightened Vigilance
- 2 September 2016
- Published by Elsevier in The Journal of Pediatrics
- Vol. 178, 288-291.e2
Effects of Targeting Higher or Lower Oxygen Saturations in Centers with More Versus Less Separation between Median Saturations
- 2 September 2016
- Published by Elsevier in The Journal of Pediatrics
- Vol. 178, 288-291.e2
Effects of Targeting Higher or Lower Oxygen Saturations in Centers with More Versus Less Separation between Median Saturations
- 1 December 2015
- Published by Elsevier in Clinics in Perinatology
- Vol. 42 (4) , 755-779
Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia
- 1 December 2015
- Published by Elsevier in Clinics in Perinatology
- Vol. 42 (4) , 755-779
Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia
- 1 December 2015
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 20 (6) , 431-435
The ethics of neonatal research: A trialists' perspective
- 1 December 2015
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 20 (6) , 431-435
The ethics of neonatal research: A trialists' perspective
- Top Cited Papers
- 1 November 2015
- Published by Elsevier in The Journal of Pediatrics
- Vol. 167 (5) , 982-986.e2
Prediction of Late Death or Disability at Age 5 Years Using a Count of 3 Neonatal Morbidities in Very Low Birth Weight Infants
- 1 November 2015
- Published by Elsevier in The Journal of Pediatrics
- Vol. 167 (5) , 982-986.e2
Top Cited PapersPrediction of Late Death or Disability at Age 5 Years Using a Count of 3 Neonatal Morbidities in Very Low Birth Weight Infants
- 17 March 2015
- Published by BMJ in Archives of Disease in Childhood
- Vol. 100 (8) , 748-753
Predicting severe motor impairment in preterm children at age 5 years
Objective To determine whether the ability to predict severe motor impairment at age 5 years improves between birth and 18 months. Design Ancillary study of the Caffeine for Apnea of Prematurity Trial. Setting and Patients International cohort of very low birth weight children who were assessed sequentially from birth to 5 years. Outcome Measures Severe motor impairment was defined as a score Results Of 1469 children, 291 (19.8%) had a severe motor impairment at 5 years. The AUC increased from 0.650 soon after birth, to 0.718 (pConclusions Prediction of severe motor impairment at 5 years of age using a cumulative risk model improves significantly from birth to 18 months of age in children with birth weights between 500 g and 1250 g. Trial registration number ClinicalTrials.gov number NCT00182312.
- 17 March 2015
- Published by BMJ in Archives of Disease in Childhood
- Vol. 100 (8) , 748-753
Predicting severe motor impairment in preterm children at age 5 years
Objective To determine whether the ability to predict severe motor impairment at age 5 years improves between birth and 18 months. Design Ancillary study of the Caffeine for Apnea of Prematurity Trial. Setting and Patients International cohort of very low birth weight children who were assessed sequentially from birth to 5 years. Outcome Measures Severe motor impairment was defined as a score Results Of 1469 children, 291 (19.8%) had a severe motor impairment at 5 years. The AUC increased from 0.650 soon after birth, to 0.718 (pConclusions Prediction of severe motor impairment at 5 years of age using a cumulative risk model improves significantly from birth to 18 months of age in children with birth weights between 500 g and 1250 g. Trial registration number ClinicalTrials.gov number NCT00182312.
- Open Access
- 1 February 2015
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 169 (2) , 188-189
Accuracy of Bayley Scores as Outcome Measures in Trials of Neonatal Therapies
- 1 February 2015
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 169 (2) , 188-189
Open AccessAccuracy of Bayley Scores as Outcome Measures in Trials of Neonatal Therapies
- 1 October 2014
- Published by Elsevier in The Journal of Pediatrics
- Vol. 165 (4) , 666-671.e2
Impact of Study Oximeter Masking Algorithm on Titration of Oxygen Therapy in the Canadian Oxygen Trial
- 1 October 2014
- Published by Elsevier in The Journal of Pediatrics
- Vol. 165 (4) , 666-671.e2
Impact of Study Oximeter Masking Algorithm on Titration of Oxygen Therapy in the Canadian Oxygen Trial
- 1 May 2014
- Published by Elsevier in The Journal of Pediatrics
- Vol. 164 (5) , 957-958
Timing of Caffeine Therapy in Very Low Birth Weight Infants
- 1 May 2014
- Published by Elsevier in The Journal of Pediatrics
- Vol. 164 (5) , 957-958
Timing of Caffeine Therapy in Very Low Birth Weight Infants